|
Novel platform for the generation of human monoclonal antibodies
|
arGEN-X BV
Tim Van Hauwermeiren MSc, CEO
Dr Molewaterplein 50,
3015 GE Rotterdam,
The Nederlands
T: +31 6 122 85 257
|
|
Biopharmaceutical R&D contract organization and developer of anti-inflammatory and anti-cancer drugs
|
Bioceros BV
Bram Bout PhD, CEO
Yalelaan 46
3584 CM Utrecht, The Netherlands
T: +31 (0)30 - 2537910
|
|
Commercialization of a fast and flexible custom microarray synthesis instrument for genomic selection in next generation sequencing and other applications.
|
FlexGen BV
Fred Dom MSc., CEO
Wassenaarseweg 72
2333 AL Leiden, The Netherlands
T: +31 71 332 22 00
|
|
Biomaterials company developing resorbable medical implants based on proprietary polymers
|
Medisse BV
Sandra de Vos
Barchman Wuytierslaan 154
3818 LM Amersfoort, The Netherlands
T: + 31 (0)650 281 838
|
|
Developer of vaccines based on proprietary adjuvant and carrier technology
|
Mucosis BV
Govert Schouten PhD, CEO
L. J. Zielstraweg 1
9713 GX Groningen, The Netherlands
T: +31 (0)50 3612112
|
|
Service Lab for molecular diagnostics and research in biomarkers
for GU cancer
|
NovioGendix BV
Bastiaan J. de Leeuw, CEO
Geert Grooteplein-Zuid 10
6525 GA Nijmegen, The Netherlands
T: + 31 (0)24 3279054
|
Unique osteoinductive materials for clinical application in bone regenerative surgery
|
Progentix Orthobiology BV
Joost D. de Bruijn PhD, CEO
Prof. Bronkhorstlaan 10-d
3723 MB Bilthoven, The Netherlands
|
|
